USA Daily Letter
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

USA Daily Letter

Politics

Trump’s CDC pick confirmed—but her pro-vaccine stance may clash with RFK Jr.’s agenda

by July 29, 2025
July 29, 2025
Trump’s CDC pick confirmed—but her pro-vaccine stance may clash with RFK Jr.’s agenda

The Senate confirmed President Donald Trump’s pick to lead the Centers for Disease Control and Prevention after his first choice struggled to gain support.

Susan Monarez, a longtime fixture in Washington who has taken on leadership positions in a number of government public health roles, was confirmed by the Senate on Tuesday, crossing yet another position off the lengthy and growing number of nominees awaiting confirmation.

Monarez was confirmed on a 51to 47party line vote.

Across her roughly two-decade career in D.C., she has served as deputy director of the Advanced Research Projects Agency for Health within the Department of Health and Human Services and in roles at the White House, including at the Office of Science and Technology Policy and the National Security Council.

She is the first CDC director to undergo the Senate confirmation process after a new law changed the requirement in 2023. Prior to her confirmation, Monarez had served as the acting director of the CDC since the beginning of this year.

But Monarez, who has a Ph.D. in microbiology and immunology, was not Trump’s first pick to lead the public health agency, which is tasked with protecting Americans from public health threats.

Trump tapped Monarez in March shortly after withdrawing his nomination of Dr. David Weldon, a former House member, after it was clear that he couldn’t get enough votes from Senate Republicans to make it across the finish line.

He lauded Monarez’s credentials, and charged that Americans had ‘lost confidence’ in the CDC.

‘Dr. Monarez will work closely with our GREAT Secretary of Health and Human Services, Robert Kennedy Jr,’ he said on social media at the time. ‘Together, they will prioritize Accountability, High Standards, and Disease Prevention to finally address the Chronic Disease Epidemic and, MAKE AMERICA HEALTHY AGAIN!’

But questions also linger on how well Monarez and Health and Human Services Secretary Robert F. Kennedy Jr. might work together.

During her confirmation hearing last month, Senate Democrats grilled Monarez over whether she agreed with Kennedy’s positions on vaccines. Kennedy has long been outspoken about his skepticism regarding vaccines, particularly COVID-19 vaccines.

The CDC has been hit with thousands of staff cuts and resignations and subject to changes in vaccine policy — notably Kennedy’s decision to remove the COVID-19 from the vaccine schedule for pregnant women and healthy children — in the last six months. 

‘I think vaccines save lives. I think that we need to continue to support the promotion of utilization of vaccines,’ Monarez said during her confirmation hearing.

Her confirmation also comes as Kennedy, in his budget request for the HHS, seeks a slash in funding to the CDC of nearly 50%, or from about $9.2 billion to $4.2 billion, for the upcoming fiscal year.

But Kennedy made clear in an X post at the time of her nomination that he supports Monarez to take on the position.

‘I handpicked Susan for this job because she is a longtime champion of MAHA values, and a caring, compassionate and brilliant microbiologist and a tech wizard who will reorient CDC toward public health and gold-standard science,’ he said. ‘I’m so grateful to President Trump for making this appointment.’

And an HHS spokesperson told Fox News Digital, ‘Once Dr. Monarez is confirmed, the Secretary looks forward to working with her to advance common-sense policies that will Make America Healthy Again.’

This post appeared first on FOX NEWS
0
FacebookTwitterGoogle +Pinterest
previous post
Union Pacific to buy Norfolk in $85 billion mega U.S. railroad deal
next post
Steve Barton: Gold, Silver, Uranium — Price Targets and Key Levels to Watch

You may also like

Rubio downplays 2028 talk, touts Vance as Trump’s...

Pro-Israel Dem says those who won’t decry Hamas...

Trump pick Emil Bove confirmed as federal judge...

White House orders Hegseth to stop polygraphs on...

Trump says his Aug 1 tariff deadline ‘will...

Rubio rips Venezuela’s Maduro as ‘narco-terrorist’ leader threatening...

Grieving parents of American terror victim plead with...

Iran’s Africa activities pose ‘significant threats to US...

Why Fetterman is right: The fight against cashless...

Freedom Caucus lawmaker Ralph Norman vows to ‘shake...

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Trump admin sanctions Brazilian judge overseeing Bolsonaro coup-plot probe

    • Top GOP senator demands probe into whether Jack Smith ‘unlawfully’ tried to influence 2024 election

    • SCOTUS to discuss Ghislaine Maxwell’s case privately in September at post-summer conference

    • Democratic lawmaker ‘no longer on speaking terms’ with some family over Israel support

    • Crypto Market Update: Ethereum Turns 10 as Trump Eyes “Golden Age of Crypto”

    Categories

    • Business (10)
    • Investing (65)
    • Politics (79)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: usadailyletter.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 usadailyletter.com | All Rights Reserved


    Back To Top